Non-injection drug use and Hepatitis C Virus: A systematic review

Drug and Alcohol Dependence

Volumn 89, Issue 1, 2007, Pages 1-12

  Scheinmann, Roberta ^a   Hagan, Holly ^a   Lelutiu Weinberger, Corina ^a   Stern, Rebecca ^a   Jarlais, Don C Des ^a,b   Flom, Peter L ^a   Strauss, Shiela ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Crack cocaine; Drug use; Epidemiology; HCV; Heroin; Non injection drug use; Prevalence

Indexed keywords

COCAINE; DIAMORPHINE; METHAMPHETAMINE;

COCAINE DEPENDENCE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG ABUSE; DRUG DEPENDENCE; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; INFECTION RISK; METHODOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VIRUS TRANSMISSION;

CAUSALITY; CROSS-SECTIONAL STUDIES; HEALTH SURVEYS; HEPATITIS C; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

HEPATITIS C VIRUS;

EID: 34247156111     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.11.014     Document Type: Review

References (47)

1. Allwright S., Bradley F., Long J., Barry J., Thornton L., and Parry J.V. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 321 (2000) 78-82
2. Alter M.J., Kuhnert W.L., and Finelli L. Guidelines for laboratory testing and result reporting of antibody to Hepatitis C Virus. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 52 (2003) 1-13 15; quiz CE1-4
3. Aragon, T., 2005. Epitools: Epidemiology Tools. R package version 0.4-7. http://www.epitools.net. Accessed September 28, 2006.
4. Baozhang T., Kaining Z., Jinxing K., Ruchang X., Ming L., Caixia Z., and Li T. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts. Epidemiol. Infect. 119 (1997) 343-347
5. Broers B., Junet C., Bourquin M., Deglon J.J., Perrin L., and Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 12 (1998) 2059-2066
6. Chang C.J., Lin C.H., Lee C.T., Chang S.J., Ko Y.C., and Liu H.W. Hepatitis C Virus infection among short-term intravenous drug users in southern Taiwan. Eur. J. Epidemiol. 15 (1999) 597-601
7. Conry-Cantilena C., VanRaden M., Gibble J., Melpolder J., Shakil A.O., Viladomiu L., Cheung L., DiBisceglie A., Hoofnagle J., and Shih J.W. Routes of infection, viremia, and liver disease in blood donors found to have Hepatitis C Virus infection. N. Engl. J. Med. 334 (1996) 1691-1696
8. Denis B., Dedobbeleer M., Collet T., Petit J., Jamoulle M., Hayani A., and Brenard R. High prevalence of Hepatitis C Virus infection in Belgian intravenous drug users and potential role of the "cotton-filter" in transmission: the GEMT Study. Acta Gastroenterol. Belg. 63 (2000) 147-153
9. Feldman J.G., Minkoff H., Landesman S., and Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm. Dis. 27 (2000) 338-342
10. Fingerhood M.I., Jasinski D.R., and Sullivan J.T. Prevalence of hepatitis C in a chemically dependent population. Arch. Int. Med. 153 (1993) 2025-2030
11. Fuller C.M., Ompad D.C., Galea S., Wu Y., Koblin B., and Vlahov D. Hepatitis C incidence-a comparison between injection and noninjection drug users in New York City. J. Urban Health 81 (2004) 20-24
12. Galperim B., Cheinquer H., Stein A., Fonseca A., Lunge V., and Ikuta N. Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. Addiction 99 (2004) 973-977
13. Garten R.J., Lai S., Zhang J., Liu W., Chen J., Vlahov D., and Yu X.F. Rapid transmission of Hepatitis C Virus among young injecting heroin users in Southern China. Int. J. Epidemiol. 33 (2004) 182-188
14. Gyarmathy V.A., Neaigus A., Miller M., Friedman S.R., and Des Jarlais D.C. Risk correlates of prevalent HIV, hepatitis B virus, and Hepatitis C Virus infections among noninjecting heroin users. J. Acquir. Immun. Defic. Syndr. 30 (2002) 448-456
15. Hagan H. Hepatitis C Virus transmission dynamics in injection drug users. Subst. Use Misuse 33 (1998) 1197-1212
16. Harsch H.H., Pankiewicz J., Bloom A.S., Rainey C., Cho J.K., Sperry L., and Stein E.A. Hepatitis C Virus infection in cocaine users-a silent epidemic. Community Ment. Health J. 36 (2000) 225-233
17. Hershow R.C., Kalish L.A., Sha B., Till M., and Cohen M. Hepatitis C Virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm. Dis. 25 (1998) 527-532
18. Hocking J., Crofts N., Aitken C., and MacDonald M. Epidemiology of the Hepatitis C Virus among injecting drug users. In: Crofts N., Dore G., and Locarnini S. (Eds). Hepatitis C: An Australian Perspective (2001), IP Communications, Victoria, Australia 260-295
19. Howe C.J., Fuller C.M., Ompad D.C., Galea S., Koblin B., Thomas D., and Vlahov D. Association of sex, hygiene and drug equipment sharing with Hepatitis C Virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 79 (2005) 389-395
20. Judd A., Hickman M., and Rhodes T. Transmission of hepatitis C-are noninjecting cocaine users at risk?. Subst. Use Misuse 37 (2002) 573-575
21. Koblin B.A., Factor S.H., Wu Y., and Vlahov D. Hepatitis C Virus infection among noninjecting drug users in New York City. J. Med. Virol. 70 (2003) 387-390
22. Lai S., Liu W., Chen J., Yang J., Li Z.J., Li R.J., Liang F.X., Liang S.L., Zhu Q.Y., and Yu X.F. Changes in HIV-1 incidence in heroin users in Guangxi Province, China. J. Acquir. Immun. Defic. Syndr. 26 (2001) 365-370
23. Maayan S., Shufman E.N., Engelhard D., and Shouval D. Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem. Addiction 89 (1994) 869-874
24. Mathei C., Robaeys G., van Damme P., Buntinx F., and Verrando R. Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences. Epidemiol. Infect. 133 (2005) 127-136
25. McMahon J.M., and Tortu S. A potential hidden source of hepatitis C infection among noninjecting drug users. J. Psychoactive Drugs 35 (2003) 455-460
26. Neaigus A., Miller M., Friedman S.R., Hagen D.L., Sifaneck S.J., Ildefonso G., and des Jarlais D.C. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 96 (2001) 847-860
27. Njoh J., and Zimmo S. Prevalence of antibodies to Hepatitis C Virus in drug-dependent patients in Jeddah, Saudi Arabia. East Afr. Med. J. 74 (1997) 89-91
28. Nyamathi A.M., Dixon E.L., Robbins W., Smith C., Wiley D., Leake B., and Longshore D. Risk factors for Hepatitis C Virus infection among homeless adults. J. Gen. Int. Med. 17 (2002) 134-143
29. Quaglio G., Lugoboni F., Pajusco B., Sarti M., Talamini G., Lechi A., Mezzelani P., and Des Jarlais D.C. Factors associated with Hepatitis C Virus infection in injection and noninjection drug users in Italy. Clin. Infect. Dis. 37 (2003) 33-40
30. Quaglio G.L., Lugoboni F., Pajusco B., Sarti M., Talamini G., Mezzelani P., and Des Jarlais D.C. Hepatitis C Virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. J. Viral Hepat. 10 (2003) 394-400
31. R Development Core Team. R: A Language and Environment for Statistical Computing (2005), R Foundation for Statistical Computing, Vienna, Austria. 3-900051-07-0. Accessed September 28, 2006 http://www.R-project.org
32. Roy K., Hay G., Andragetti R., Taylor A., Goldberg D., and Wiessing L. Monitoring Hepatitis C Virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol. Infect. 129 (2002) 577-585
33. Santana Rodriguez O.E., Male Gil M.L., Hernandez Santana J.F., Liminana Canal J.M., and Martin Sanchez A.M. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur. J. Epidemiol. 14 (1998) 555-561
34. Shannon K., Ishida T., Morgan R., Bear A., Oleson M., Kerr T., and Tyndall M.W. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm. Reduct. J. 3 (2006) 1
35. Sherlock D.S. Chronic hepatitis C. Dis. Mon. Mar. 40 (1994) 117-196
36. Shirin T., Ahmed T., Iqbal A., Islam M., and Islam M.N. Prevalence and risk factors of Hepatitis B Virus, Hepatitis C Virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J. Health Popul. Nutr. 18 (2000) 145-150
37. Shrestha S.M., Subedi N.B., Shrestha S., Maharjan K.G., Tsuda F., and Okamoto H. Epidemiology of Hepatitis C Virus infection in Nepal. Trop. Gastroenterol. 19 (1998) 102-104
38. Sogolow E., Peersman G., Semaan S., Strouse D., and Lyles C.M. The HIV/AIDS Prevention Research Synthesis Project: scope, methods, and study classification results. J. Acquir. Immun. Defic. Syndr. 30 Suppl. 1 (2002) S15-S29
39. Strasfeld L., Lo Y., Netski D., Thomas D.L., and Klein R.S. The association of Hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J. Acquir. Immun. Defic. Syndr. 33 (2003) 356-364
40. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., and Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 283 (2000) 2008-2012
41. Tortu S., Neaigus A., McMahon J., and Hagen D. Hepatitis C among noninjecting drug users: a report. Subst. Use Misuse 36 (2001) 523-534
42. Tortu S., McMahon J.M., Pouget E.R., and Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst. Use Misuse 39 (2004) 211-224
43. Thomson Scientific, Science Citation Index. Accessed April 16, 2006. URL: http://www.isiknowledge.com.
44. van Ameijden E.J., van den Hoek J.A., Mientjes G.H., and Coutinho R.A. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur. J. Epidemiol. 9 (1993) 255-262
45. Wada K., Greberman S.B., Konuma K., and Hirai S. HIV and HCV infection among drug users in Japan. Addiction 94 (1999) 1063-1069
46. Ward H., Pallecaros A., Green A., and Day S. Health issues associated with increasing use of "crack" cocaine among female sex workers in London. Sex Transm. Infect. 76 (2000) 292-293
47. World Health Organization. Wkly. Epidemiol. Rec. 73 (1998) 145-153